Subscribe

Advocacy News

New Hampshire Senate Bill 581 (SB581) was introduced into the New Hampshire Senate in January 2018. It amends the definition of “compounding” to preclude the preparation of a single dose of a nonhazardous, commercially available drug or licensed biologic for administration to an individual patient prepared in accordance with the manufacturer’s approved labeling.

ATAP strongly supports a mandatory pass-through, as it would directly benefit patients by reducing their costs at the pharmacy counter.

As of December 2017, 32 states and the District of Columbia have adopted USP 797 into law, including New Hampshire. Once adopted, a state agency, which is typically the state’s Board of Pharmacy, must be appointed to oversee and enforce these standards.


Results 1 - 3 of 3
  • American Health and Drug Benefits
  • Lynx CME
  • Value Based Care in Rheumatology
  • Oncology Practice Management
  • Urology Practice Management

Search